Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucowave M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

UHC Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glucowave M 1mg/500mg Tablet

Diabetace Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetace Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are paramount in diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and know how to treat them; maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glucowave M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glucowave M 1mg/500mg Tablet:

Administer Glucowave M 1mg/500mg Tablet as prescribed by your physician, ingesting the entire tablet with food. Do not alter the tablet in any way; chewing, crushing, or breaking is prohibited.

Common Side effects of Glucowave M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucowave M 1mg/500mg Tablet:

Consume Glucowave M 1mg/500mg tablets as prescribed by your physician, adhering strictly to the recommended dosage and treatment period. Ingest the tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

How Glucowave M 1mg/500mg Tablet works:

Glucowave M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glucowave M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucowave M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingUNSAFE

Lactation and Glucowave M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glucowave M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glucowave M 1mg/500mg tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucowave M 1mg/500mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glucowave M 1mg/500mg Tablets are typically initiated at a reduced dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glucowave M 1mg/500mg Tablet :

Should you forget a Glucowave M 1mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glucowave M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glucowave M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glucowave M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glucowave M 1mg/500mg Tablets and seek immediate medical attention.
Glucowave M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glucowave M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glucowave M 1mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some research.
Glucowave M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glucowave M 1mg/500mg tablets and alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glucowave M 1mg/500mg Tab...
56
MRP 65
13% off